EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseVergleichsstudieOpen Access · CC BY-NC-ND 4.0

Safety of Potassium‐Competitive Acid Blockers Compared With Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease and Peptic Ulcer Disease: A Systematic Review and Meta‐Analysis

Yewon Jang iD, Jongho Park, Dahee Kang, Jae Hyun Kim, Hyuk Soon Choi iD, Ha-Lim Jeon, Hankil Lee iD

Journal of Gastroenterology and Hepatology · 2026-01 · 41 (1) · 28-40

DOI: 10.1111/jgh.70178 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 02.12.2025. Verfasst von Yewon Jang und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Ajou University, Suwon, Republic of Korea. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Peptic Ulcer, Gastroesophageal Reflux. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim Potassium‐competitive acid blockers (P‐CABs) are a novel class of acid suppressants developed to overcome the limitations of proton pump inhibitors (PPIs), providing rapid and sustained acid suppression. While PPI‐related adverse events (AEs) are well‐documented, safety data on P‐CABs remain limited. This study systematically reviewed AEs of P‐CABs compared with PPIs, with a meta‐analysis focusing on hypergastrinemia.

Methods

Following a preregistered PROSPERO protocol (CRD42024565011), we searched for randomized controlled trials (RCTs) and observational studies comparing P‐CABs and PPIs in patients with gastroesophageal reflux disease or peptic ulcer disease. Frequently reported AEs and serious AEs (SAEs) were qualitatively synthesized; hypergastrinemia was quantitatively analyzed using a random‐effects model.

Results

Ten RCTs and one observational study were included. Nine studies reported specific AEs, with diarrhea reported in seven studies and constipation, nasopharyngitis, and liver‐related events, each reported in three. Most AEs had reporting rates below 5%, except diarrhea, nasopharyngitis, and upper respiratory tract inflammation, which exceeded 5% in both groups. Fracture demonstrated the largest relative difference between the groups, with a threefold higher rate in the P‐CAB group. SAEs were observed in fewer than 10% of patients in both groups in most studies. A meta‐analysis of six studies showed greater serum gastrin elevation in the P‐CAB group compared with the PPI group (mean difference: 130.92 pg/mL, 95% confidence intervals: 36.37–225.47).

Conclusions

P‐CABs demonstrate a comparable AE risk to PPIs but monitoring for hypergastrinemia and hepatic dysfunction is essential. Further research is required to support safer clinical use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsPeptic UlcerGastroesophageal RefluxHumansGastrinsRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

gastroesophageal reflux diseasemeta‐analysispotassium‐competitive acid blockersproton pump inhibitorssystematic review

Substanzen

Proton Pump InhibitorsGastrins

Autor:innen und Institutionen

  • College of Pharmacy, Ajou University, Suwon, Republic of Korea.
  • Department of BioHealth Regulatory Science, Graduate School of Ajou University, Suwon, Republic of Korea.
  • School of Pharmacy and Institute of new Drug Development, Jeonbuk National University, Jeonju, Republic of Korea.
  • Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.
  • College of Pharmacy, Ewha Womans University, Seoul, Republic of Korea.

ORCID-Profile: Yewon Jang, Hyuk Soon Choi, Hankil Lee

Zitieren

APA

Jang, Y., Park, J., Kang, D., Kim, J. H., Choi, H. S., Jeon, H. L., & Lee, H. (2026). Safety of Potassium‐Competitive Acid Blockers Compared With Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease and Peptic Ulcer Disease: A Systematic Review and Meta‐Analysis. Journal of Gastroenterology and Hepatology, 41(1), 28-40. https://doi.org/10.1111/jgh.70178

Vancouver

Jang Y, Park J, Kang D, Kim JH, Choi HS, Jeon HL, et al. Safety of Potassium‐Competitive Acid Blockers Compared With Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease and Peptic Ulcer Disease: A Systematic Review and Meta‐Analysis. Journal of Gastroenterology and Hepatology. 2026;41(1):28-40. doi:10.1111/jgh.70178

BibTeX
@article{Jang2026,
  author = {Jang, Yewon and Park, Jongho and Kang, Dahee and Kim, Jae Hyun and Choi, Hyuk Soon and Jeon, Ha-Lim and Lee, Hankil},
  title = {Safety of Potassium‐Competitive Acid Blockers Compared With Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease and Peptic Ulcer Disease: A Systematic Review and Meta‐Analysis},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2026},
  volume = {41},
  number = {1},
  pages = {28--40},
  doi = {10.1111/jgh.70178}
}
Kostenlos starten →